Advertisement

Topics

Abraxis Pharmaceutical Products, Inc Company Profile

19:26 EST 23rd November 2017 | BioPortfolio

Abraxis Pharmaceutical Products, Inc. is a specialty pharmaceutical company that fulfills an important need in the medical community as a provider of a broad portfolio of injectable pharmaceutical products, including difficult to manufacture, urgently needed medical products. Generic Injectable Business
APP's portfolio of more than 150 products ranks the company among the market share leaders in each of its areas of focus - oncology, anti-infective and critical care injectable pharmaceuticals. The company has a deep pipeline of approximately 50 products in various stages of development, which includes a number of product applications pending at the FDA. APP has expanded its product portfolio with the receipt of an industry leading 39 product approvals between 2001 and 2004. As of July 2005, the company continued this momentum with four new generic product approvals from the FDA.

Location

1501 East Woodfield Road, Suite 300 East
Schaumburg
Illinois
60173-5837
United States of America

Contact

Phone: (847) 413-2075
Fax: (800) 743-7082
Email: contactus@appdrugs.com


News Articles [656 Associated News Articles listed on BioPortfolio]

Abraxis Glyphosate strip test kits

The Abraxis Glyphosate strip test is a rapid immunochromatographic test designed solely for use in the qualitative screening of glyphosate in water and food samples. For food samples such as honey, le...

Shimadzu Scientific Instruments, Cure Pharmaceutical, CK Sciences Form Strategic Alliance for R&D of Pharmaceutical Cannabis Products

Collaborative agreement will focus on researching and developing safer pharmaceutical cannabis-based products and moving these products through clinical trials using FDA guideline

Kazakhstan - New regulations for medicinal products in the pipeline

The Ministry of Health in Kazakhstan is introducing changes to the existing legislation for distribution of pharmaceutical products and medical devices with the view to improve regulation of prices an...

FDA announces recall of some liquid pharmaceutical products

(HealthDay)—The U.S. Food and Drug Administration has announced a recall of numerous liquid pharmaceutical products because of possible bacterial contamination that could cause severe infections in ...

View Press Release

The global pharmaceutical filtration market is expected to grow at a CAGR of more than 11 % during the forecast period. The increasing prevalence of heart attacks and diabetes has increased the demand...

Global Onychomycosis Tinea Unguium Drug Market 2012 2022 [Report Updated: 01042017] Prices from USD $1600

SummaryBased on products type, the report describes major products type share of regional market. Products mentioned as follows: By Type Oral ExternalBased on region, the report describes major...

Global Chlorhexidine Gluconate Solution Market 2012 2022 [Report Updated: 01032017] Prices from USD $2600

SummaryBased on products type, the report describes major products type share of regional market. Products mentioned as follows: By Grade Medicine Grade Cosmetic GradeBased on region, the repor...

Chugai sheds older products to focus on innovation

Japan’s Chugai Pharmaceutical is to sell 13 so-called long-listed products - branded drugs that are…

Drugs and Medications [418 Associated Drugs and Medications listed on BioPortfolio]

Abraxane [Abraxis BioScience, LLC]

These highlights do not include all the information needed to use ABRAXANE safely and effectively. See full prescribing information for ABRAXANE ABRAXANE® for Injectable Suspension (paclitaxel protei...

Emetrol cherry [WellSpring Pharmaceutical Corporation]

Emetrol

Cetirizine hydrochloride [Pharmaceutical Associates, Inc.]

Cetirizine Hydrochloride Syrup

Giltuss total release [Gil Pharmaceutical Corp]

Drug Facts

Gilphex tr [Gil Pharmaceutical Corp]

Drug Facts

PubMed Articles [1265 Associated PubMed Articles listed on BioPortfolio]

Application of recombinant Factor C reagent for the detection of bacterial endotoxins in pharmaceutical products.

Recombinant Factor C (rFC) is non-animal derived reagent used to detect bacterial endotoxins in pharmaceutical products. Despite the fact that the reagent was first commercially available nearly 15 ye...

Biodegradable Microparticles for Simultaneous Detection of Counterfeit and Deteriorated Edible Products.

In an era of globalized trade relations where food and pharmaceutical products cross borders effortlessly, consumers face counterfeit and deteriorated products at elevated rates. This paper presents m...

Patient-centered drug delivery and its potential applications for unmet medical needs.

Pharmaceutical dosage forms address diverse key components but satisfying unmet patient needs to enhance patient adherence is a major challenge. The desired design of patient-centered drug products sh...

Comparative stability-indicating chromatographic methods for determination of 4-hexylresorcinol in pharmaceutical formulation and shrimps.

Three chromatographic stability-indicating methods were developed for determination of 4-hexylresorcinol in pure form and in a pharmaceutical formulation. Method A was based on a gradient elution liqu...

Pharmaceutical Equivalence of Clarithromycin Oral Dosage Forms Marketed in Nairobi County, Kenya.

Clarithromycin is a broad-spectrum semi-synthetic macrolide indicated for treatment of pneumonias, Helicobacter pylori, and chlamydial and skin infections. The object of this study was to evaluate the...

Clinical Trials [1091 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Risperidone 1 mg Tablets of Torrent Pharmaceuticals Limited, India and Risperdal® (Risperidone) 1 mg Tablets of Janssen Pharmaceutical Products, LP, USA, in Healthy Human Adult Subjects, Under Fed Conditions

Objective: - To assess the bioequivalence of Risperidone 1.0 mg tablets of Torrent Pharmaceuticals Limited., India and Risperdal® (Risperidone) 1.0 mg tablets of Janssen Pharmace...

Pharmaceutical Care for Asthma Control Improvement (PHARMACI)-Study

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.

Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for diabetes type 2 patients. Patients will be randomly allocated to th...

A Study Comparing the Bioequivalence of Triamcinolone Acetonide Aqueous Nasal Spray (Apotex, Inc.) to That of Nasacort® AQ Nasal Spray (Sanofi-Aventis Pharmaceutical Products, Inc.) In the Treatment of Seasonal Allergic Rhinitis

A randomized, double-blind, placebo-controlled parallel-group study, comparing the bioequivalence of triamcinolone acetonide aqueous nasal spray (Apotex, Inc.) to that of Nasacort® AQ nas...

Improving Compliance Among Elderly Polypharmacy Users Through Community Pharmacy Based Pharmaceutical Care Program

The aim of the project is to evaluate effectiveness of a multidimensional pharmaceutical care plan in improving compliance among elderly polypharmacy users at community pharmacy settings. ...

Companies [2553 Associated Companies listed on BioPortfolio]

Abraxis Pharmaceutical Products, Inc

Abraxis Pharmaceutical Products, Inc. is a specialty pharmaceutical company that fulfills an important need in the medical community as a provider of a broad portfolio of injectable pharmaceutical pro...

Abraxis Bioscience

Abraxis BioScience is an integrated, global biopharmaceutical company dedicated to meeting the needs of critically ill patients. The company develops, manufactures, and markets one of the broadest por...

Abraxis BioScience, Inc.

Abraxis BioScience is a fully integrated global biotechnology company dedicated to the discovery, development and delivery of next-generation therapeutics and core technologies th...

P V S P H A R M A

Our Pharmaceutical products solution is focused to help manage the success of client’s business. We thrive on our innovative methodology to provide solution at an unmatched time to delivery and pr...

Osmotica Pharmaceutical Corp.

Osmotica Pharmaceutical is a global specialty pharmaceutical company with a proven history of developing commercially successful pharmaceutical products. The company uses its prop...

More Information about "Abraxis Pharmaceutical Products, Inc" on BioPortfolio

We have published hundreds of Abraxis Pharmaceutical Products, Inc news stories on BioPortfolio along with dozens of Abraxis Pharmaceutical Products, Inc Clinical Trials and PubMed Articles about Abraxis Pharmaceutical Products, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Abraxis Pharmaceutical Products, Inc Companies in our database. You can also find out about relevant Abraxis Pharmaceutical Products, Inc Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record